P's and Blues: Potentiation of Propoxyphene Withdrawal by a Variety of Antihistamines
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 22 (4) , 397-402
- https://doi.org/10.3109/15563658408992570
Abstract
Three cases are presented of patients who experienced potentiation of propoxyphene's effects by different antihistamines. These included increased analgesia and mild euphoria as well as moderately severe symptoms of opiate withdrawal at therapeutic doses of propoxyphene. In one case, withdrawal symptoms were blocked with clonidine, an alpha-2 agonist. Since the specific antihistamine-opiate combination, pentazocine and tripelennamine, is associated with increased lethality, physicians are cautioned to avoid combining propoxyphene with antihistamines.This publication has 11 references indexed in Scilit:
- Clonidine in maniaDrug Development Research, 1983
- HISTAMINE-MEDIATED ADENYLATE-CYCLASE STIMULATION IN HUMAN MYOCARDIUM1982
- Potentiation of Lethality in Mice by Combinations of Pentazocine and TripelennamineClinical Toxicology, 1980
- The Analgesic and Hypothermic Effects of Nefopam, Morphine, Aspirin, Diphenhydramine, and PlaceboThe Journal of Clinical Pharmacology, 1980
- Biology of Opioid PeptidesAnnual Review of Pharmacology and Toxicology, 1979
- CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMSThe Lancet, 1978
- Complications of Propoxyphene AbuseArchives of internal medicine (1960), 1973
- THE ACTIONS OF HISTAMINE ON THE MAMMALIAN HEARTThe Journal of Pharmacology and Experimental Therapeutics, 1967
- ACTIONS OF HISTAMINE ON MAMMALIAN HEART1967
- MILD ANALGESICS A REVIEW OF THEIR CLINICAL PHARMACOLOGY (Part II)The Lancet Healthy Longevity, 1966